Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Mol Biosyst. 2016 May 24;12(6):1772–1780. doi: 10.1039/c6mb00024j

Figure 2.

Figure 2

(A) Structure of known proton-pump inhibitor, Rabeprazole (B) Gastric H+/K+-ATPase activity is inhibited by 100μM Rabeprazole. (C) Benzimidazole probes inhibit ATPase activity by approximately 50% at 10μM compound.